{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:32:28Z","timestamp":1769761948194,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s13555-024-01151-x","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T13:01:52Z","timestamp":1715259712000},"page":"1359-1366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cutaneous Superficial Basal Cell Carcinoma\u00a0is a Basal Cell Carcinoma In Situ: Electron Microscopy of a Case Series of Basal Cell Carcinomas"],"prefix":"10.1007","volume":"14","author":[{"given":"Harsimran","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"de Mesy Bentley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Minhaj","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce R.","family":"Smoller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"issue":"10","key":"1151_CR1","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","volume":"151","author":"HW Rogers","year":"2015","unstructured":"Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol. 2015;151(10):1081\u20136. https:\/\/doi.org\/10.1001\/jamadermatol.2015.1187.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"1151_CR2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/(sici)1097-0215(19981005)78:2<144::aid-ijc3>3.0.co;2-z","volume":"78","author":"M Staples","year":"1998","unstructured":"Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985\u20131995: are primary prevention programs starting to have an effect? Int J Cancer. 1998;78(2):144\u20138. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19981005)78:2%3c144::aid-ijc3%3e3.0.co;2-z.","journal-title":"Int J Cancer"},{"issue":"5","key":"1151_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1524-4725.2009.01124.x","volume":"35","author":"AS Casey","year":"2009","unstructured":"Casey AS, Kennedy CE, Goldman GD. Mohs micrographic surgery: how ACMS fellowship directors practice. Dermatol Surg. 2009;35(5):747\u201356. https:\/\/doi.org\/10.1111\/j.1524-4725.2009.01124.x.","journal-title":"Dermatol Surg"},{"issue":"4","key":"1151_CR4","first-page":"20","volume":"5","author":"MS Nestor","year":"2012","unstructured":"Nestor MS, Zarraga MB. The incidence of nonmelanoma skin cancers and actinic keratoses in South Florida. J Clin Aesthet Dermatol. 2012;5(4):20\u20134.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"5","key":"1151_CR5","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","volume":"166","author":"A Lomas","year":"2012","unstructured":"Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069\u201380. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10830.x.","journal-title":"Br J Dermatol"},{"key":"1151_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/archderm.1965.01600070044004","volume":"91","author":"GA Gellin","year":"1965","unstructured":"Gellin GA, Kopf AW, Garfunkel L. Basal cell epithelioma. Arch Dermatol. 1965;91:38\u201345. https:\/\/doi.org\/10.1001\/archderm.1965.01600070044004.","journal-title":"Arch Dermatol"},{"key":"1151_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/1097-0142(196405)17:5<609::aid-cncr2820170510>3.0.co;2-l","volume":"17","author":"AH Mehregan","year":"1964","unstructured":"Mehregan AH, Pinkus H. Intraepidermal epithelioma: a critical study. Cancer. 1964;17:609\u201336. https:\/\/doi.org\/10.1002\/1097-0142(196405)17:5%3c609::aid-cncr2820170510%3e3.0.co;2-l.","journal-title":"Cancer"},{"issue":"2","key":"1151_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jaad.2018.03.060","volume":"80","author":"MC Cameron","year":"2019","unstructured":"Cameron MC, Lee E, Hibler BP, et al. Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol. 2019;80(2):303\u201317. https:\/\/doi.org\/10.1016\/j.jaad.2018.03.060.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"1151_CR9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29479","volume":"14","author":"PR Cohen","year":"2022","unstructured":"Cohen PR. Cutaneous basal cell carcinoma in situ: a case series. Cureus. 2022;14(9):e29479. https:\/\/doi.org\/10.7759\/cureus.29479.","journal-title":"Cureus"},{"key":"1151_CR10","doi-asserted-by":"publisher","DOI":"10.5070\/D330163285","author":"PR Cohen","year":"2024","unstructured":"Cohen PR. Basal cell carcinoma in situ of the skin revisted: case reports of the superficial type and fibroepithelioma type of this in situ cutaneous neoplasm. Dermatol Online J. 2024. https:\/\/doi.org\/10.5070\/D330163285.","journal-title":"Dermatol Online J"},{"key":"1151_CR11","unstructured":"Cohen PR. Superficial basal cell carcinoma of the skin is a cutaneous basal cell carcinoma in situ. SKINmed. In press."},{"key":"1151_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1063-5823(05)56002-2","volume":"56","author":"AK Nicholas","year":"2005","unstructured":"Nicholas AK, Jacques PB. Morphology and ultrastructure of basement membranes. Curr Top Membr. 2005;56:19\u201342. https:\/\/doi.org\/10.1016\/S1063-5823(05)56002-2.","journal-title":"Curr Top Membr"},{"key":"1151_CR13","doi-asserted-by":"publisher","unstructured":"Tozawa T, Ackerman BA. Basal cell carcinoma with follicular differentiation.\u00a0Am J Dermatopathol. 1988;10(5):457\u2013466. https:\/\/doi.org\/10.1097\/00000372-198712000-00002.","DOI":"10.1097\/00000372-198712000-00002"},{"issue":"5","key":"1151_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/00000372-198910000-00011","volume":"11","author":"J Rosai","year":"1989","unstructured":"Rosai J. Basal cell carcinoma with follicular differentiation. Am J Dermatopathol. 1989;11(5):479\u201397.","journal-title":"Am J Dermatopathol"},{"key":"1151_CR15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/00000372-198712000-00002","volume-title":"Ackerman\u2019s histologic diagnosis of neoplastic skin diseases: a method by pattern analysis. Neoplasms with follicular differentiation","author":"AB Ackerman","year":"1993","unstructured":"Ackerman AB, de Viragh PA, Chongchitnant N, Reddy V, di Leonardo M. Basal cell carcinoma with follicular differentiation (Chapter 26). In: Ackerman\u2019s histologic diagnosis of neoplastic skin diseases: a method by pattern analysis. Neoplasms with follicular differentiation. Philadelphia: Lea & Febiger; 1993. p. 605\u201358. https:\/\/doi.org\/10.1097\/00000372-198712000-00002."},{"issue":"Suppl 2","key":"1151_CR16","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1038\/modpathol.3800512","volume":"19","author":"AN Crowson","year":"2006","unstructured":"Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol. 2006;19(Suppl 2):S127\u201347. https:\/\/doi.org\/10.1038\/modpathol.3800512.","journal-title":"Mod Pathol"},{"issue":"3","key":"1151_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/1523-1747.ep12260190","volume":"82","author":"M Kallioinen","year":"1984","unstructured":"Kallioinen M, Autio-Harmainen H, Dammert K, Risteli J, Risteli L. Discontinuity of the basement membrane in fibrosing basocellular carcinomas and basosquamous carcinomas of the skin: an immunohistochemical study with human laminin and type\u00a0IV collagen antibodies. J Invest Dermatol. 1984;82(3):248\u201351. https:\/\/doi.org\/10.1111\/1523-1747.ep12260190.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1151_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/1523-1747.ep12466209","volume":"88","author":"SH Barsky","year":"1987","unstructured":"Barsky SH, Grossman DA, Bhuta S. Desmoplastic basal cell carcinomas possess unique basement membrane-degrading properties. J Invest Dermatol. 1987;88(3):324\u20139. https:\/\/doi.org\/10.1111\/1523-1747.ep12466209.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1151_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.0022-202X.2003.22114.x","volume":"122","author":"J Iida","year":"2004","unstructured":"Iida J, Wilhelmson KL, Price MA, et al. Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth. J Invest Dermatol. 2004;122(1):167\u201376. https:\/\/doi.org\/10.1046\/j.0022-202X.2003.22114.x.","journal-title":"J Invest Dermatol"},{"key":"1151_CR20","unstructured":"In situ. Online etymology dictionary. 2022. https:\/\/www.etymonline.com\/word\/in%20situ. Accessed 8 June 2023."},{"key":"1151_CR21","unstructured":"Davis CP. Definition of in situ. TxList. March 29, 2021. https:\/\/www.rxlist.com\/in_situ\/definition.htm. Accessed 8 June 2023."},{"key":"1151_CR22","unstructured":"National Cancer Institute. Carcinoma in situ [NCI\u2019s dictionary of cancer terms]. Dec 4, 2014. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/carcinoma-in-situ. Accessed 8 June 2023."},{"issue":"18","key":"1151_CR23","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1080\/14656566.2023.2284351","volume":"24","author":"A Villani","year":"2023","unstructured":"Villani A, Scalvenzi M, Micali G, et al. An update on the current and emerging pharmacotherapies for basal cell carcinomas. Expert Opin Pharmacother. 2023;24(18):2143\u201351. https:\/\/doi.org\/10.1080\/14656566.2023.2284351.","journal-title":"Expert Opin Pharmacother"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01151-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-024-01151-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-024-01151-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T13:29:09Z","timestamp":1716470949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-024-01151-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1151"],"URL":"https:\/\/doi.org\/10.1007\/s13555-024-01151-x","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"20 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Harsimran Kaur, MD, MBBS, Karen L. de Mesy Bentley, MS, Syed Minhaj Rahman, BS, MD and Bruce R. Smoller, MD have nothing to disclose. Philip R. Cohen is an Editorial Board member of<i> Dermatology and Therapy<\/i>. Philip R. Cohen was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All of the patients gave consent for being part of study or being part of subsequent publications. This study was approved by the Institutional Review Board (IRB) of the University of Rochester Medical Center (URMC), Research Subjects Review Board (STUDY00007788).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}